SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001306923-19-000005
Filing Date
2019-02-14
Accepted
2019-02-14 16:43:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A Karyopharm_13GA3.htm SC 13G/A 51679
  Complete submission text file 0001306923-19-000005.txt   53250
Mailing Address 470 UNIVERSITY AVE PALO ALTO CA 94301
Business Address 470 UNIVERSITY AVE PALO ALTO CA 94301 650-325-0772
Palo Alto Investors LP (Filed by) CIK: 0001306923 (see all company filings)

IRS No.: 770558164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Subject) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87705 | Film No.: 19607527
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1